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 Concerns exist regarding potential differences in transgene product expression 
following gene delivery in immunocompetent versus immunocompromized animal 
models. To address this question in vitro, this study evaluated expression of green 
flourescent protein (GFP) in bone marrow-derived mesenchymal stem cells (BMDMSC) 
from immuncompetent and athymic nude rats following GFP gene delivery using a first-
generation adenoviral vector.  Cell types used were from 2-4-week old Wistar (Wstr) rats 
and 10-week-old NIH-rnu nude rats (Nude) of both sexes, and a BMDMSC from Lewis 
rats (Tul).  Intensity and duration of GFP expression were documented every 48 hours in 
live cells using an in vivo imaging system with a cooled charge-coupled device camera.  
Intensity was measured in flux (photons/cm2/second/steradian). Expression was 
compared between cell types in cells in monolayer and three-dimensional alginate culture 
conditions.  Flux values from days 0, 7, 12, and 22 were used for statistical comparisons. 
There was no significant difference in GFP expression between groups 
(immunocompetent versus immunocompromized).  Rat breed and immune status had no 
effect on GFP expression (P >0.8, monolayer; P>.60, alginate). Background flux was 
2.50x106 for cells in monolayer culture and 1.42x106 for cells in alginate constructs. The 
AdGFP-transduced cells had 1800-fold greater expression, when compared with 
background values, in monolayer culture, and 525-fold greater expression in alginate 
constructs. Cells cultured in monolayer showed significantly greater expression compared 
to those in alginate constructs (P<0.05).  These findings will provide valuable 
information for selection of optimal target cells for gene delivery using Ad vectors, and 
may alleviate concerns regarding potential differences in transgene expression between 
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Impaired fracture healing and osteoarthritis are sources of morbidity in dogs1, rats, 
horses, humans2 and other species and the incidence of both increases with age. 
Osteoarthritis (OA) is a disease that affects the joints of the body causing pain and 
disability.  It is a disease that lacks an effective treatment and mostly affects the hips, 
knees and distal interphalangeal joints of the hands3.  Fractures can occur in any bone of 
the body, near joints or in the long bones.  Approximately 10-15% of fractures in human 
patients will become delayed or non-unions2, i.e. they will not heal within a reasonable 
time period, based on clinical criteria. In both OA and delayed and non-union fractures, 
augment of biologic processes is indicated for the alleviation of pain and disability. 
One of the most promising potential therapies is gene therapy. Reporter genes are 
commonly used to confirm the function of gene delivery systems. Prior to the 
development of potentially therapeutic transgene constructs, it is essential that the 
efficiency of new gene delivery systems be validated by the use of reporter genes. Green 
fluorescent protein (GFP), found in nature in the jellyfish (Aquoria victoria), is a widely 
used, reliable reporter gene. Numerous vector systems have been evaluated for the 
delivery of cDNAs of interest to cells, in both in vivo and ex vivo gene delivery systems. 
In this study, a recombinant human adenovirus was chosen because this vector has a high 
transduction efficiency, is easy to propagate with high titers at a reasonable cost, and it 
can transduce both dividing and ordinary cells4. 
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 Bone morphogenetic proteins (BMPs) are a family of growth factors shown to 
improve fracture healing by inducing osteogenic differentiation of mesenchymal 
progenitor cells via the mechanism of endochondral ossification.  The most widely used 
and studied BMPs are BMP-2 and BMP-76.  They also been successfully used in clinical 
settings for spine fusion and management of recalcitrant non-union fractures of the tibia7,8.  
Bone marrow derived mesenchymal stem cells (BMDMSC) promote bone healing 
by their ability to differentiate into osteoblasts and chondrocytes, as well as other 
mesenchymal cells9, and as such, have been used extensively as gene delivery targets10. 
Immunodeficient animal models have been used to evaluate various gene therapy systems 
in vivo, providing the obvious advantage of the opportunity for allograft and xenograft 
cell transplantation. However, questions exist concerning the translational research 
potential of such models. Regardless of these concerns, immunocompetent animal models 
will continue to serve as valuable screening tools for the preliminary assessment of gene 
therapy techniques prior to more rigorous testing in immunocompetent animals. 
One of the delivery vehicles which has been well-studied to date is alginate, a 
linear copolymer derived from the kelp plant (Macrocystis pyrifera). Alginate is 
economical to purchase and store. It also has the important advantage of ease of handling, 
which becomes relevant when looking toward translational applications.  
The purpose of the study reported here was to evaluate and compare GFP 
expression in BMDMSC from immunocompetent and athymic nude rats. Our hypothesis 
was that GFP expression in BMDMSC from athymic nude rats and those from Wistar 
(immunocompetent) rats would differ in neither intensity nor duration of transgene 
expression. Our specific goal was to evaluate GFP expression by documenting duration 
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 and intensity of fluorescence detected in cells from both immunocompetent and athymic 
rats by imaging of transgene product production in live cells.  Bioluminescence imaging 
has been used as an acceptable evaluation in other models11.  Determining the differences 
in expression of GFP between these two cell types will provide valuable information to 
be used in the selection of optimal target cells for gene delivery using Ad vectors. 
 
MATERIALS AND METHODS 
Cell Culture 
Bone marrow derived mesenchymal stem Cell types used were from 2-4-week old Wistar 
(Wstr) rats and 10-week-old NIH-rnu nude rats (Nude) of both sexes, and a BMDMSC 
from Lewis rats* (Tul).  Cells were expanded in monolayer culture in using Tulane 
Complete Culture Medium.  Media contained alpha-MEM with L-glutamine 
supplemented with 20% fetal bovine serum (FBS), additional L-gluatmine (200mM in 
0.85% NaCl; final concentration 2mM), penicillin, (final concentration 100 units/ml and 
100µ), and streptomycin (final concentration 100µg/ml).   
*Some of the materials employed in this work were provided by the Tulane Center for 
Gene Therapy through a grant from NCRR of the NIH, Grant No. P40RR017447. 
 
Monolayer 
Cells were placed in 48 well clear plates with 1000 cells per well when seeded at Day -1 
(Day 0 = day of transduction).  Cells were transduced for 2 hours with an adenoviral-GFP 
transgene construct containing a first generation adenoviral vector (AdGFP)12.  After 2 
hours all virus was aspirated off and replaced with 700µl of Tulane CCM.  Starting at 
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 Day 0, the fluorescence of the cells was measured using a commercially available in vivo 
imaging system (IVIS®, Xenogen Corporation, Alameda, CA). 
Alginate 
Cells were plated at a seeding density of 500,000 cells per well in 75mm2 plates and 
incubated at 37°C, 5% CO2, until 75% confluent.  Three plates were transduced with an 
adenoviral-GFP transgene construct containing a first generation adenoviral vector 
(AdGFP)12 at a total multiplicity of infection (MOI) of 10,000:1 for two hours at 37°C.  
All media was aspirated from cells and replaced with 6ml trypsin-EDTA (1x) for 15 
minutes 37°C, 5%CO2.  Trypsin action was stopped by adding 6ml of Tulane CCM 
media to each dish.  Cells were then centrifuged at 1400rpm for 10 minutes.  Media was 
aspirated off and cells were rinsed with 6ml GBSS and centrifuged at the same speed and 
time.  Using a 1cc syringe and 20 gauge needle cells were re-suspended in 200μl of 1.2% 
Na alginate.  A pipette was then used to measure 50µl of the mixture for one bead and 
placed in CaCl2 for 10 minutes.  Beads were then rinsed three times in 0.9% NaCl and 
placed in a 96 well plate, one bead per well with 75µl Tulane CCM.  The cells were then 
scraped and made into alginate beads, containing approximately 5.0x105 cells per 
alginate bead.  The beads were then placed in a 96-well black plate containing clear well 
bottoms with Tulane CCM in each well.  Fluorescence imaging began at Day 0.    
Histological Staining 
Staining for alkaline phosphatase production was performed using a commercially 
available kit per the manufacturer’s instruction (Sigma kit No. 85, Sigma-Aldrick, St. 
Louis, MO).  Staining for mineral using the performed using the von Kossa method.  
Statistical Analysis 
 6
 Unpaired t-tests were done to compare expression at Days 0, 7, 12, 22. .  A one-way 
ANOVA was performed to determine the difference of GFP expression across the three 
different cell types, Nude, Tulane, and Wstr cells.  Individual tests were run for the 




There was no significant difference in GFP expression between groups 
(immunocompetent versus immunocompromized).  Rat breed and immune status had no 
effect on GFP expression (P >0.8, monolayer; P>.60, alginate). Flux values, expressed as 
a ratio of median expression in AdGFP-transduced cells to background levels, were as 
follows: Monolayer Day 0 -7792/1; Day 7 – 2634/1; Day 12 – 2592/1; Day 22 – 
3819/1;Alginate Day 0 – 2304/1; Day 7- 529/1; Day 12 – 488/1; Day 22 421/1. 
Background flux was 2.50x106 for cells in monolayer culture and 1.42x106 for cells in 
alginate constructs. The AdGFP-transduced cells had 1800-fold greater expression, when 
compared with background values, in monolayer culture, and 525-fold greater expression 
in alginate constructs. Cells cultured in monolayer showed significantly greater 






 Figures 1 and 2 show expression of cells in both monolayer and alginate construct at Day 
0.  
 
Figure 1.  Figure 2.  
Figures 3 and 4 show expression of cells in both monolayer and alginate construct at Day 
22.  
 





We conclude that in this in vitro model of transgene expression in monolayer and 
three-dimensional alginate cultures, there is no difference in transgene expression 
between cells from immunocompetent animals and those of from immunodeficient nude 
rats. 
Cells in monolayer had greater transgene product expression than those in 
alginate.  This may be due to a decreased ability for nutrient exchange between the 
culture medium cells in this system.  Cells in monolayer have free access to media and 
therefore can transport the necessary molecules for protein production. 
 However, this is only one factor that could have caused the lack of expression.  
The cells themselves could have suffered damage from being frozen and thawed that 
prevented the virus from transduction.  
 These results provide us with more information with which to pursue in vivo 
studies and decrease the concern regarding potential impairment of transgene expression 
in cells from immunodeficient animals.  It has shown that adenovirus can be used as a 
successful vehicle to deliver genetic material into cells and express protein for an 
extended period of time.  This can lead to further study using therapeutic genes to 
promote the expression of protein in multiple tissues.   
 The fact that there was no statistical difference between the immunocompotent 
and immunodeficient cell lines leads to the idea that the immunocompotent cells may be 
used to delivery vehicles themselves, such as in the alginate construct.  Further study 
could also be done using different scaffolding to determine a better source to introduce 
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 desired protein in vivo.  Overall it shows potential for the use of gene therapy to aid in the 
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